It is Time to Start Thinking About the Big Picture - Hatchard Report
Last night we watched A House of Dynamite on Netflix. The plot revolved around a nuclear missile strike on Chicago by an unnamed rogue nation| Hatchard Report
Calgary, Alberta – August 18, 2025 – Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively “Marvel” or the “Company”), , a drug discovery company developing novel therapeutics for autism spectrum disorder and related conditions, today announced that the China National Intellectual Property Administration (CNIPA) has granted patent number ZL202180020893.4, titled “Purine Compounds for Treating Disorders”....| Marvel Biosciences
Last night we watched A House of Dynamite on Netflix. The plot revolved around a nuclear missile strike on Chicago by an unnamed rogue nation| Hatchard Report
Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks to grow its pipeline.| STAT
House lawmakers recently passed an amendment en bloc in their version of the fiscal 2026 NDAA that would mandate the secretary of defense to set up such trainings. The post As China advances, Congress wants DOD to get up to speed on biotechnology appeared first on DefenseScoop.| DefenseScoop
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.| STAT
The winners include a gene therapy for a rare form of deafness, a drug for vaping addiction, and a generic antibiotic.| STAT
And more biotech news brought to you by The Readout newsletter.| STAT
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a pharma CEO and a toddler in a tuxedo.| STAT
Can "food noise" be measured? Telehealth giant Ro is rolling out a new scale for obesity care.| STAT
Can Trump take credit for North Carolina's booming biopharma industry? Which drugs could get a shortcut to the market? All that and more on this week's episode of "The Readout…| STAT
New analysis finds the median net price for 154 newly launched drugs, when adjusted for inflation and manufacturer discounts, rose by 51% between 2022 and 2024.| STAT
Five patients have been hospitalised in Queensland after ingesting the rat poison brodifacoum. ABC reports that the authorities do not know the| Hatchard Report
Plus more biotech news, brought to you by The Readout.| STAT
Enhertu can help patients with breast cancer when given earlier in the disease, according to data presented at the ESMO Conference 2025.| STAT
Mercer County Community College's new offering aims to train students for careers in biotechnology and cell therapy. The post MCCC launches aseptic biomanufacturing program, mobile lab appeared first on NJBIZ.| NJBIZ
NZ First have admitted they voted to progress an amended version of the Gene Technology Bill out of the select committee stage and return it to the whole| Hatchard Report
CPA Economist Andrew Rechenberg gave his testimony and answered questions in a four- panelist hearing. It was arguably the most agreeable hearing in years. A bipartisan consensus on America’s generic drug supply chain is nearly fully formed now.| Coalition For A Prosperous America
The Health Select Committee has reported back to Parliament with its recommendations on the Gene Technology Bill. Their 25 page report begins with the following sentence: “The Health Committee has examined the Gene Technology Bill and recommends by majority that it be passed.” There are nine members of the Committee. Three National Party MPs and […]| Hatchard Report
This article examines genetically modified yeast in detail and shows how the biotech food industry is deceiving even consumer activists An article in the UK Telegraph entitled “M&S accused of misleading shoppers with bread ingredients” reports that Marks and Spencer supermarkets have been mislabelling bread. A white loaf with a prominent label claiming “only four […]| Hatchard Report
The Listener has published an article entitled “NZ spends more on health than most countries – so why is our health system still sick?“. The article follows the case of a woman from Thames who was diagnosed with appendicitis upon presentation to her local ED. She was transferred to Waikato hospital for an operation but […]| Hatchard Report
Associate Minister for Agriculture Mark Patterson, has announced that NZ First will oppose the passage of the Gene Technology Bill in its current form because the party is opposed to the release of genetically modified organisms into the environment, since their subsequent spread cannot be contained. Patterson told Newsroom: “The stuff that happens in containment in […]| Hatchard Report
Whole foods are disappearing in favour of biosynthetic GM ingredients Modern medicine has evolved a concept of the ‘active ingredient’. The phrase refers to a specific chemical or molecular constituent of a medicine that is considered to have a therapeutic effect. Originally, most common medicines were prepared using whole plants. In the modern era, the idea that […]| Hatchard Report
You may have noticed a profusion of packaged goods which claim to be healthy because they are 'low fat'. Weight loss products command a massive global| Hatchard Report
Experts from across the pharmaceutical and biotechnology landscape share trends, challenges, and opportunities for using AI in drug discovery. The post AI in Drug Discovery: Key Insights from a Computational Biology Roundtable appeared first on Digital Science.| Digital Science
With temperatures on the rise and a growing concern about our natural resources, scientists are searching for renewable energy sources in order to help combat climate change. Could bionic mushrooms help? This article is part of our WinSPIRE Science in the News series. Authors: Reema Pedaballi and Sungyu Lim| The Pipettepen
Tom Burns, CEO of cutting-edge eyecare technology company Glaukos of California, made a checklist before seeking a site to build a multimillion-dollar| Huntsville Business Journal
After decades of resistance and regulatory delays, genetically modified (GM) wheat has reached a pivotal stage in the United States. This article analyses HB4 drought-tolerant wheat developed by Bioceres Crop Solutions, with particular attention to its approval for cultivation by the USDA in August 2024 and the subsequent commercialisation partnership announced in September 2025 with […] The post GM wheat lands in the United States appeared first on FoodTimes.| FoodTimes
An EMBL alumnus’ work with tRNA, along with support from EMBLEM, has led to a start-up, Umlaut.bio, positioned to aid drug development.| EMBL
Larissa Chan explores the field of optogenetics, dissecting the potential innovations and flaws of this novel technique. The post Optogenetics: Medicine or manipulation appeared first on The Oxford Scientist.| The Oxford Scientist
ETH Zurich researchers discover Galdieria sulphuraria's unique ability to convert formic acid into high-quality protein, achieving 89-100% biomass yields. This breakthrough opens new pathways for sustainable protein production and regulatory approval challenges in the EU.| FoodTimes
Scientific innovation—especially in AI, biotech, and quantum—are matters of national security, ethics, and global influence.| Fancy Comma, LLC
Calgary, Alberta, Canada, August 11, 2025 – Marvel Biosciences Corp. (TSX-V: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), announces the award of 142,987 deferred share units (“DSUs”) to two of Marvel’s directors, in lieu of cash payment for directors’ fees.| Marvel Biosciences
Pushing the economy forward: Together with public and private sector partners, UBC and its researchers are fuelling job creation and solving real-world challenges When Dr. Pieter Cullis arrived at UBC as an undergraduate physics student in 1964, he had no idea he would one day help develop a scientific breakthrough…| UBC News
AI and biotechnology could solve humanity’s toughest problems — or trigger chaos, collapse, and dystopia. Mustafa Suleyman’s The Coming Wave warns we’re not ready. Can we contain what we’ve unleash…| Unsolicited Feedback
Peyton Soethout, MJLST Web Content Editor| LawSci Forum
A new study from Harvard's Brigham and Women's Hospital shows how pills could be used to deliver mRNA vaccines and treatments for other diseases too.| SingularityHub
The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.| STAT
Investors are in panic as Australian drug companies could be the next victims in an expansion of the US trade war.| Australian Financial Review
Cellugy's first lab-made ingredient is EcoFLEXY, a powder cellulose-based rheology modifier or substance that improves viscosity.| Beauty Independent
Precision medicine is reshaping healthcare by tailoring treatments to a person’s genetic makeup, lifestyle, and environment.| Market Research Blog
According to authoritative pharmaceutical industry online Endpoints News:| Hatchard Report
From pharmaceuticals to biofuels and beyond, bioprocess engineering plays a pivotal role in bringing us the products that improve our lives and advance our societies. In this article, we’ll delve into the intricate world of bioprocess engineering. We’ll uncover its fundamental components, its wide-ranging applications across various industries, the challenges it faces, and the innovations that [...] The post Bioprocess Engineering: Turning Cells into Products appeared first on Explore Bi...| Explore Biotech
Biotechnology, the application of biology and engineering to create innovative solutions, has revolutionized the healthcare industry in numerous ways. From decoding the human genome to developing cutting-edge medical devices, biotechnology engineering has played a pivotal| Explore Biotech
The post Marvel Biosciences to Give Oral Presentation at the Annual IRSF Rett Syndrome Scientific Meeting appeared first on Marvel Biosciences.| Marvel Biosciences
Incredibly, the Telegraph reports that the British government has decided to approve experiments to 'dim the light of the sun'. The British boffins (is that| Hatchard Report
The National Security Commission on Emerging Biotechnology (NSCEB) has released a pivotal report highlighting the strategic importance of biotechnology to U.S. national security and expressing concern over China’s rapid advancements in this sector. The report underscores that the United States, historically a leader in biotechnology, is now at risk of falling behind in critical areas as China surges ahead.| Green Chemicals Blog
First we set out the background, later we will draw out the implications as we stand on the threshold of an unfettered era of biotech experimentation.| Hatchard Report
There is a poem written by Harry Baker If ever I die and thee be not sure that I’m deadJust put butter and jam on fresh baked breadThen wave them vittles over me headIf my mouth don’t open, thee be sure that I’m dead Appreciation of bread is a universal language. Cultures all over the […]| Hatchard Report Media
First we set out the background, later we will draw out the implications as we stand on the threshold of an unfettered era of biotech experimentation. An article in the 28th March NY Times is entitled Top F.D.A. Vaccine Official Resigns, Citing Kennedy’s ‘Misinformation and Lies’. It reports the ‘resignation’ of Dr Peter Marks, who […]| Hatchard Report Media
On the so-called 5th anniversary of COVID-19 (which evidence shows actually started circulating around five and half years ago), two big German newspapers—Zeit and Süddeutsche Zeitung— have broken an important story.. Back in early 2020 the German intelligence service concluded with 80-95% accuracy that COVID-19 resulted from a lab leak at Wuhan, but Chancellor Angela Merkel deliberately buried the report as did her successor Olaf Scholz. The German public and members of parliament were...| Hatchard Report Media
The post Marvel Biosciences to File for Orphan Drug Designation with the U.S. FDA for MB-204 as a Treatment for Rett Syndrome appeared first on Marvel Biosciences.| Marvel Biosciences
Discover insightful recommendations for further reading after "Living Intelligence." Explore the intersection of AI, biotechnology, and advanced sensors to expand your knowledge.| AI for CEOs
On the so-called 5th anniversary of COVID-19 (which evidence shows actually started circulating around five and half years ago), two big German| Hatchard Report
The following is the text of our oral submission to the New Zealand Health Select Committee on the Gene Technology Bill made on Monday. We were allowed 10| Hatchard Report
This article has two parts: the problem and our response.| Hatchard Report
The following is the text of our oral submission to the New Zealand Health Select Committee on the Gene Technology Bill made on Monday. We were allowed 10 minutes. The NZ First MP asked a sympathetic question at the conclusion, enabling me to finish with some unscripted points about the threat to small farmers. “Good […]| Hatchard Report Media
This article has two parts: the problem and our response.| Hatchard Report Media
After the bombshell information in our last two releases (see here and here) everyone has to consider their position very carefully. We reported the results| Hatchard Report
Many of you have written and asked about the current prevalence of genetically modified foods and the potential health risks. An up to date answer to this| Hatchard Report
A year ago Jennifer Doudna, Nobel Laureate co-inventor of CRISPR gene editing technology announced a ground breaking project to edit human and animal| Hatchard Report
The post Living Intelligence: The Convergence of AI, Biotechnology, and Advanced Sensors appeared first on AI for CEOs.| AI for CEOs
There is little doubt in anyone's mind that we are at a crossroads. New Zealand legislation is in progress to deregulate biotechnology experimentation. If| Hatchard Report
We have arrived at the crossroads of our lifetime| Hatchard Report Media
Currently, there are 19,350 doctors in New Zealand; that's one for every 264 people. According to Hon. Judith Collins, our Minister for Business Innovation| Hatchard Report
This release contains template suggestions to make a submission to the Health Select Committee querying the provisions of the Gene Technology Bill which was| Hatchard Report
Formal Response to the Expert Opinions Issued by the Science Media Centre in Support of the Gene Technology Bill introduced to Parliament.| Hatchard Report
In Brooklyn, researchers debate whether aging is a disease to be treated with biotech breakthroughs or a natural stage of life.| Scienceline
It's too early to know how well the method would work in people—but it just might be possible to one day swap out needles for pills.| SingularityHub
Rather than training the algorithm on content scraped from the internet, scientists trained the AI on nearly three million genomes.| SingularityHub
Dubbed “electro-agriculture,” the approach uses solar panels to trigger a chemical reaction that turns ambient CO2 into an energy source called acetate.| SingularityHub
Charting the "dark matter" of the viral universe has implications not just for biotechnology—but potentially for battling the next pandemic too.| SingularityHub
Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments, including novel anticancer therapies, medical compounds, vaccines, cosmetics, and a wide array of natural products and extracts. With a dedicated team of scientists, Altogen Labs provides a comprehensive suite of laboratory services, utilizing the latest technologies […] The post Preclinical Research with Advanced Oncology Models and Immunooncolo...| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
AI-designed proteins that morph with the flick of a switch could bring selective drug delivery, monitor disease in the body, or form biological circuits.| Singularity Hub
Scientist plan to test the idea in humans. If safe and effective, the long-lasting shot could help people who don’t have regular access to antiviral drugs.| Singularity Hub
Many potent antibiotics are toxic. Researchers used AI to reengineer one so it maintained its bug-killing abilities without harming human cells.| Singularity Hub
Best known for its ability to rid infected mice of their fear of cats, the mind-controlling parasite travels from gut to brain and releases proteins.| Singularity Hub
The AI Act introduces a series of obligations in relation to AI systems which may pose a high risk. This guide aims to help businesses navigate the obligations they must satisfy concerning high-risk AI systems.| WILLIAM FRY
Blocking a protein that promotes inflammation in middle age increased metabolism, lowered muscle wasting and frailty, and reduced the chances of cancer.| Singularity Hub
Scientists discover new gene editing tools in bacterial "jumping genes" that can be modified to cut, paste, and flip any sequence of DNA.| SingularityHub
Overriding natural evolution, gene drives could add genes that make weeds more vulnerable to herbicides or reduce their pollination and numbers.| SingularityHub
DARPA is developing stimulants with a molecular “light switch." A pulse of infrared light from a helmet would turn the drugs on and off in the brain.| SingularityHub
In over 40 studies released last week, researchers found that radiation and low gravity rapidly changed the body’s inner workings.| SingularityHub
The burgeoning weight-loss drug industry could be worth as much as $200 billion within the next decade, according to Barclays bank.| CNBC
Atlantic Fish Co, a startup that’s cultivating seafood from fish cells, has secured a $100,000 loan from the North Carolina Biotechnology Center. Jen Greenstein, senior director of investments at NCBiotech, said the loan will help both Atlantic Fish and the broader cellular agriculture industry in North Carolina.| North Carolina Research Campus
August 2, 2023 Today we are happy to announce the launch of a new lungs-targeted in vivo transfection reagent. The reagent is crafted to transport small molecules, DNA, RNA, and proteins to the lungs tissue, aiming to treat lung diseases, including cystic fibrosis and lung cancer. The transfection reagent is a non-viral complex comprising nanoparticle-sized […] The post Lungs-Targeted Transfection Reagent: Safe and Effective Delivery of Biomolecules appeared first on Transfection Reagents |...| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
Free Online Moles-to-Grams Calculator The post Moles to Grams Calculator appeared first on Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems.| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
LAS VEGAS, NEVADA – July 19, 2021 – Altogen Biosystems, leading manufacturer of in vivo transfection products, announced today that Altogen’s nanoparticle-based in vivoTransfection reagent (catalog #5031) was demonstrated to be effective for glioblastoma-targeted co-delivery of plasmid DNA (3.7 kb) and chemically modified siRNA. This transfection reagent was used in over 30 research publications, demonstrating highly […] The post In Vivo Nanoparticle Transfection Reagent is Effective...| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
A stable cell line is a population of cells that have been genetically modified to express a specific gene or RNA molecule of interest on a stable basis. Stable cell lines are generated by introducing the gene or RNA molecule into the cells and selecting for cells that have stably incorporated the genetic material and […] The post Stable Cell Line appeared first on Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems.| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
Transfection is considered as a major laboratory method to integrate protein, RNA and DNA molecules into tissues and cells. Delivery of plasmid DNA molecules containing gene inserts, messenger RNA and small interfering RNA molecules that regulate gene expression (i.e. microRNA, siRNA) into the primary cells and cancer cell lines have been extensively utilized by scientists. […] The post How do I increase transfection efficiency? appeared first on Transfection Reagents | Cell Lines, In Vivo ...| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
July 27, 2021 – Altogen Biosystems® is a biotechnology manufacturing company that specializes in the development and testing of optimized cell transfection reagents and kits for both in vitro and in vivo delivery. In 2018 Altogen Biosystems launched the AltoFect transfection reagent formulated for difficult-to-transfect cells (like B-cells, T-cells), and primary cell cultures that are […] The post Crossing Blood-Brain Barrier: Delivery of Biomolecules into Glioblastoma Enabled by Altogen...| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
The need to measure cell proliferation effects is vast, including testing the effects of growth factors, novel pharmacological agents, cytotoxicity assessment or investigating cell activation. Cell proliferation assays utilize a stain or substrate to make a correlation between the readout and the number of remaining cells post-treatment. However, the means of assessing cell number varies […] The post Quantitate in vitro anti-proliferation experiments using a metabolic assay (Alamarblue,...| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
HIVEOPOLIS Beekeepers’ Survey (EN) In our project HIVEOPOLIS, we aim to combine traditional beekeeping with advanced technologies to create the beehive of the future and establish a symbiosis of humans, bees, and technology. To achieve this ambitious aim, we ask you to tell us which kind of technology you would like to have in your beehives. Please click… Read More »HIVEOPOLIS – Beekeepers’ Survey| HIVEOPOLIS
GROWING THERAPEUTIC BEEHIVES In summertime, Paul Stamets (D.Sc, Mycologist) has noticed in his garden a continuous convoy of bees from his beehive to his mycelium. This was not a surprising event since in the wild, also, the mycelium and honeybee territories are closely located. But, he thought that the bees might be benefiting from the… Read More »Growing Therapeutic Beehives| HIVEOPOLIS
